Dr. Beer is an internationally recognized leader, holding appointments as deputy director of the Knight Cancer Institute, Chief Medical Officer at OHSU’s Knight Cancer Institute Cancer Early Detection Advanced Research Center, professor in the OHSU School of Medicine, head of the Prostate Cancer Research Program, and the Grover C. Bagby Endowed Chair for Prostate Cancer Research prior to joining Exact. He has also authored and co-authored more than 280 articles, playing a leading role in establishing a new global standard of care for patients. In addition to his role at Exact Sciences, Dr. Beer is continuing as an adjunct professor of medicine and sees patients with prostate cancer at OHSU.
Framing the Future of Cancer Screening Multi-cancer Early Detection Testing
Cancer is often detected too late. MCED liquid biopsy tests are designed to harness the power of a variety of biomarkers from various tumors to help detect cancer prior to symptom onset. We’ll share the current evidence for novel multi-analyte approaches to MCED testing that, in combination with standard of care screening, may have the potential to detect more cancers at earlier stages when they are more treatable.
Track Chair: Cindy Perettie, Roche